Cocktail of gp63 and Hsp70 induces protection against Leishmania donovani in BALB/c mice

Enhanced efficacy and immunogenicity of 78kDa antigen formulated in various adjuvants against murine visceral leishmaniasis

(2010) Rajeev Nagill et al.   VACCINE

Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE

(2010) Joelma Trigo et al.   VACCINE

Immunogenicity and Efficacy of Single Antigen Gp63, Polytope and PolytopeHSP70 DNA Vaccines against Visceral Leishmaniasis in Experimental Mouse Model

(2009) Rakhee Sachdeva et al.   PLoS One

Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune® in Brazilian endemic areas

(2009) Clarisa B. Palatnik-de-Sousa et al.   VACCINE

gp63 in Stable Cationic Liposomes Confers Sustained Vaccine Immunity to Susceptible BALB/c Mice Infected with Leishmania donovani

(2008) S. Bhowmick et al.   INFECTION AND IMMUNITY

Effect of dose and route of inoculation on the generation of CD4+ Th1/Th2 type of immune response in murine visceral leishmaniasis

(2008) Sukhbir Kaur et al.   PARASITOLOGY RESEARCH

Immunogenicity of HSP-70, KMP-11 and PFR-2 leishmanial antigens in the experimental model of canine visceral leishmaniasis

(2008) Eugenia Carrillo et al.   VACCINE

Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein

(2008) Ana Paula Fernandes et al.   VACCINE